Structure

InChI Key FDDDEECHVMSUSB-UHFFFAOYSA-N
Smiles Nc1ccc(S(N)(=O)=O)cc1
InChI
InChI=1S/C6H8N2O2S/c7-5-1-3-6(4-2-5)11(8,9)10/h1-4H,7H2,(H2,8,9,10)

Physicochemical Descriptors

Property Name Value
Molecular Formula C6H8N2O2S
Molecular Weight 172.21
AlogP -0.08
Hydrogen Bond Acceptor 3.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 1.0
Polar Surface Area 86.18
Molecular species NEUTRAL
Aromatic Rings 1.0
Heavy Atoms 11.0

Bioactivity

Mechanism of Action Action Reference
Bacterial dihydropteroate synthase inhibitor INHIBITOR PubMed PubMed PubMed
Assay Description Organism Bioactivity Reference
Inhibition of human cytosolic isozyme Carbonic anhydrase II at 20 degree C None 300.0 nM
Inhibitory activity against Human carbonic anhydrase II None 300.0 nM
Inhibition of human carbonic anhydrase II Homo sapiens 300.0 nM
Inhibition constant (Ki) against human cloned carbonic anhydrase II (CAH) None 300.0 nM
Inhibitory activity against human carbonic anhydrase II (CA2) None 300.0 nM
Inhibitory activity against human recombinant carbonic anhydrase II None 300.0 nM
Inhibition of human carbonic anhydrase II None 300.0 nM
Inhibitory activity against human recombinant carbonic anhydrase II (CA2) None 300.0 nM
Inhibitory activity against human carbonic anhydrase II (hCA II) by using esterase assay method None 300.0 nM
Inhibition of human carbonic anhydrase II (hCA II) None 300.0 nM
Inhibitory activity against human tumor-associated transmembrane carbonic anhydrase IX. None 294.0 nM
Inhibition constant determined against catalytic domain of human cloned carbonic anhydrase IX None 294.0 nM
Inhibitory activity against human cloned carbonic anhydrase isozyme IX, by CO2 hydrase assay method. None 294.0 nM
Inhibitory activity against human carbonic anhydrase IX (hCA IX) by using CO2 hydrase assay method None 294.0 nM
Inhibitory activity against murine carbonic anhydrase XIII (mCA XIII) by using CO2 hydrase assay method None 32.0 nM
Inhibition of cloned isozyme, human carbonic anhydrase II None 300.0 nM
Inhibitory constant against human Carbonic anhydrase II Homo sapiens 300.0 nM
Inhibitory constant against human Carbonic anhydrase IX Homo sapiens 294.0 nM
Ki value against human carbonic anhydrase II Homo sapiens 240.0 nM
Ki value against human carbonic anhydrase VII Homo sapiens 70.0 nM
Ratio against Carbonic anhydrase II to Carbonic anhydrase IX Homo sapiens 1.02 Ratio
Ki value against murine carbonic anhydrase XIII Mus musculus 32.0 nM
Inhibitory activity against human carbonic anhydrase II (hCAII) Homo sapiens 300.0 nM
Inhibitory activity against human carbonic anhydrase II expressed in Escherichia coli BL21 Homo sapiens 300.0 nM
Inhibitory activity against human carbonic anhydrase IX expressed in Escherichia coli BL21 Homo sapiens 294.0 nM
Inhibitory activity against human carbonic anhydrase II Homo sapiens 300.0 nM
Inhibitory constant against catalytic domain of human carbonic anhydrase IX Homo sapiens 294.0 nM
Inhibitory constant against catalytic domain of human carbonic anhydrase XII Homo sapiens 37.0 nM
Inhibitory activity against alpha carbonic anhydrase (Zn-Cam) from Methanosarcina thermophila Methanosarcina thermophila 250.0 nM
Inhibitory potency against human cloned Carbonic anhydrase II expressed in Escherichia coli strain BL21 Homo sapiens 300.0 nM
Inhibitory activity against catalytic domain of human carbonic anhydrase XII Homo sapiens 37.0 nM
Inhibitory potency against catalytic domain of human Carbonic anhydrase IX expressed in Escherichia coli strain BL21 Homo sapiens 294.0 nM
Inhibition constant against human recombinant carbonic anhydrase II Homo sapiens 300.0 nM
Inhibition constant against human recombinant carbonic anhydrase IX catalytic domain Homo sapiens 294.0 nM
Zone of inhibition of Escherichia coli at compound concentration of 40 mg/mL Escherichia coli 16.5 mm
Zone of inhibition of Escherichia coli at compound concentration of 80 mg/mL Escherichia coli 18.0 mm
Zone of inhibition of Bacillus subtilis at compound concentration of 40 mg/mL Bacillus subtilis 10.5 mm
Zone of inhibition of Bacillus subtilis at compound concentration of 80 mg/mL Bacillus subtilis 11.5 mm
Zone of inhibition of Escherichia coli at compound concentration of 160 mg/mL Escherichia coli 20.5 mm
Zone of inhibition of Salmonella typhae at compound concentration of 40 mg/mL Salmonella enterica subsp. enterica serovar Typhi 7.0 mm
Zone of inhibition of Salmonella typhae at compound concentration of 80 mg/mL Salmonella enterica subsp. enterica serovar Typhi 7.5 mm
Zone of inhibition of Bacillus subtilis at compound concentration of 160 mg/mL Bacillus subtilis 13.0 mm
Zone of inhibition of Salmonella typhae at compound concentration of 160 mg/mL Salmonella enterica subsp. enterica serovar Typhi 7.5 mm
Zone of inhibition of Staphylococcus aureus at compound concentration of 40 mg/mL Staphylococcus aureus 20.5 mm
Zone of inhibition of Staphylococcus aureus at compound concentration of 80 mg/mL Staphylococcus aureus 22.5 mm
Zone of inhibition of Pseudomonas aeruginosa at compound concentration of 40 mg/mL Pseudomonas aeruginosa 13.5 mm
Zone of inhibition of Pseudomonas aeruginosa at compound concentration of 80 mg/mL Pseudomonas aeruginosa 15.5 mm
Zone of inhibition of Staphylococcus aureus at compound concentration of 160 mg/mL Staphylococcus aureus 25.0 mm
Zone of inhibition of Pseudomonas aeruginosa at compound concentration of 160 mg/mL Pseudomonas aeruginosa 17.5 mm
Inhibitory activity against human Carbonic anhydrase II (hCA II) Homo sapiens 300.0 nM
Inhibitory activity against human Carbonic anhydrase IX (hCA IX) Homo sapiens 294.0 nM
Inhibitory activity against human Carbonic anhydrase XII (hCA XII) Homo sapiens 37.0 nM
Inhibitory activity against human recombinant cytosolic CA2 Homo sapiens 240.0 nM
Inhibition of human recombinant carbonic anhydrase 2 by stopped-flow CO2 hydrase assay Homo sapiens 240.0 nM
Inhibition of Helicobacter pylori recombinant carbonic anhydrase by stopped-flow CO2 hydrase assay Helicobacter pylori 454.0 nM
Inhibition of human recombinant CA2 Homo sapiens 240.0 nM
Inhibition of Helicobacter pylori recombinant CA Helicobacter pylori 431.0 nM
Inhibition of full length human recombinant CA VI Homo sapiens 941.0 nM
Inhibition of human recombinant cytosolic isozyme CA II by stopped-flow CO2 hydrase method Homo sapiens 240.0 nM
Inhibition of catalytic domain of human recombinant CA IX Homo sapiens 238.0 nM
Inhibition of human CYP2C9 assessed as (S)-Flurbiprofen hydroxylation Homo sapiens -17.8 %
Inhibition of human recombinant CA2 by CO2 hydration stopped flow assay Homo sapiens 240.0 nM
Inhibition of human recombinant CA9 by CO2 hydration stopped flow assay Homo sapiens 294.0 nM
Inhibition of human recombinant CA12 by CO2 hydration stopped flow assay Homo sapiens 37.0 nM
Inhibition of human recombinant carbonic anhydrase 2 by stopped flow CO2 hydration assay Homo sapiens 240.0 nM
Inhibition of human recombinant CA2 by stopped-flow CO2 hydrase assay Homo sapiens 240.0 nM
Inhibition of human recombinant carbonic anhydrase 2 by stopped flow CO2 hydrase assay Homo sapiens 240.0 nM
Inhibition of human full length recombinant carbonic anhydrase 6 by stopped flow CO2 hydrase assay Homo sapiens 941.0 nM
Inhibition of human recombinant carbonic anhydrase 9 catalytic domain by stopped flow CO2 hydrase assay Homo sapiens 238.0 nM
Inhibition of human recombinant carbonic anhydrase 2 by stopped flow CO2 hydration method Homo sapiens 240.0 nM
Inhibition of Cryptococcus neoformans recombinant Can2 by stopped-flow CO2 hydration assay Cryptococcus neoformans 765.0 nM
Inhibition of Helicobacter pylori beta-carbonic anhydrase by stopped-flow CO2 hydration assay Helicobacter pylori 240.0 nM
Inhibition of human recombinant CA2 by stopped-flow CO2 assay Homo sapiens 240.0 nM
Inhibition of cloned Stylophora pistillata alpha-CA expressed in human HEK293 cells by stopped-flow CO2 assay Stylophora pistillata 364.0 nM
Inhibition of human recombinant CA2 by stopped-flow hydration assay Homo sapiens 240.0 nM
Inhibition of human recombinant CA2 by stopped flow CO2 hydrase assay Homo sapiens 240.0 nM
Inhibition of human recombinant CA3 by stopped flow CO2 hydrase assay Homo sapiens 988.0 nM
Inhibition of human recombinant CA6 by stopped flow CO2 hydrase assay Homo sapiens 941.0 nM
Inhibition of human recombinant CA7 by stopped flow CO2 hydrase assay Homo sapiens 70.0 nM
Inhibition of human recombinant CA9 by stopped flow CO2 hydrase assay Homo sapiens 238.0 nM
Inhibition of human recombinant CA12 by stopped flow CO2 hydrase assay Homo sapiens 37.0 nM
Inhibition of human recombinant CA13 by stopped flow CO2 hydrase assay Homo sapiens 32.0 nM
Inhibition of human recombinant carbonic anhydrase 2 after 15 mins by stopped flow carbon dioxide hydrase assay method Homo sapiens 240.0 nM
Inhibition of human recombinant carbonic anhydrase 2 after 15 mins by CO2 hydration method Homo sapiens 240.0 nM
Binding affinity to bovine carbonic anhydrase 2 Bos taurus 851.14 nM
Inhibition of human recombinant carbonic anhydrase 2 preincubated for 15 mins by stopped-flow CO2 hydrase assay Homo sapiens 240.0 nM
Inhibition of human recombinant CA2 by stopped-flow CO2 hydration assay Homo sapiens 240.0 nM
Inhibition of human recombinant CA6 by stopped-flow CO2 hydration assay Homo sapiens 941.0 nM
Inhibition of Stylophora pistillata carbonic anhydrase by stopped-flow CO2 hydration assay Stylophora pistillata 364.0 nM
Inhibition of Stylophora pistillata carbonic anhydrase 2 by stopped-flow CO2 hydration assay Stylophora pistillata 300.0 nM
Inhibition of human carbonic anhydrase II by spectrophotometry at pH 7.5 Homo sapiens 240.0 nM
Inhibition of Cryptococcus neoformans recombinant Can2 beta-carbonic anhydrase after 15 mins by stopped flow CO2 hydration assay Cryptococcus neoformans 770.0 nM
Inhibition of human recombinant alpha-carbonic anhydrase 2 after 15 mins by stopped flow CO2 hydration assay Homo sapiens 240.0 nM
Inhibition of human full length cytosolic isoform of carbonic anhydrase 2 preincubated for 15 mins by CO2 hydration stopped-flow assay Homo sapiens 240.0 nM
Inhibition of human recombinant catalytic domain of carbonic anhydrase 9 preincubated for 15 mins by stopped-flow CO2 hydration assay Homo sapiens 294.0 nM
Inhibition of human recombinant catalytic domain of carbonic anhydrase 12 preincubated for 15 mins by stopped-flow CO2 hydration assay Homo sapiens 37.0 nM
Inhibition of human recombinant carbonic anhydrase 2 at pH 7.5 by stopped flow CO2 hydration assay Homo sapiens 240.0 nM
Inhibition of human carbonic anhydrase 2-catalyzed CO2 hydration activity by stopped flow assay Homo sapiens 240.0 nM
Inhibition of human carbonic anhydrase 9-catalyzed CO2 hydration activity by stopped flow assay Homo sapiens 294.0 nM
Inhibition of human carbonic anhydrase 12-catalyzed CO2 hydration activity by stopped flow assay Homo sapiens 37.0 nM
Inhibition of human recombinant carbonic anhydrase 2 after 15 mins by stopped flow CO2 hydration assay Homo sapiens 240.0 nM
Inhibition of human wild type carbonic anhydrase 2 expressed in Escherichia coli after 15 mins preincubation by stopped flow CO2 hydration assay Homo sapiens 240.0 nM
Inhibition of human wild type carbonic anhydrase 2 Asn67Ile mutant expressed in Escherichia coli after 15 mins preincubation by stopped flow CO2 hydration assay Homo sapiens 363.0 nM
Inhibition of human wild type carbonic anhydrase 2 Gln92Val mutant expressed in Escherichia coli after 15 mins preincubation by stopped flow CO2 hydration assay Homo sapiens 296.0 nM
Inhibition of human wild type carbonic anhydrase 2 Leu204Ser mutant expressed in Escherichia coli after 15 mins preincubation by stopped flow CO2 hydration assay Homo sapiens 251.0 nM
Inhibition of human cloned carbonic anhydrase 2 preincubated for 15 mins by stopped flow CO2 hydration assay Homo sapiens 240.0 nM
Inhibition of human carbonic anhydrase 9 catalytic domain preincubated for 15 mins by stopped flow CO2 hydration assay Homo sapiens 294.0 nM
Inhibition of human carbonic anhydrase 12 catalytic domain preincubated for 15 mins by stopped flow CO2 hydration assay Homo sapiens 37.0 nM
Inhibition of human carbonic anhydrase 2 preincubated for 15 mins measured for 10 to 100 sec by stopped-flow method Homo sapiens 240.0 nM
Inhibition of Cryptococcus neoformans Can2 preincubated for 15 mins measured for 10 to 100 sec by stopped-flow method Cryptococcus neoformans 765.0 nM
Inhibition of GST-tagged Malassezia globosa ATCC 96807/CBS 7966 MG-CA expressed in Escherichia coli BL21(DE3) cells preincubated for 15 mins measured for 10 to 100 sec by stopped-flow method Malassezia globosa CBS 7966 245.0 nM
Inhibition of recombinant Vibrio cholerae carbonic anhydrase expressed in Escherichia coli (DE3) preincubated for 15 mins by stopped-flow CO2 hydrase assay Vibrio cholerae 471.0 nM
Cytotoxicity against Homo sapiens (human) MDA-MB-231 cells after 48 hr by MTT assay Homo sapiens 90.0 nM
Cytotoxicity against Homo sapiens (human) HepG2 cells after 48 hr by MTT assay Homo sapiens 80.0 nM
Cytotoxicity against Homo sapiens (human) K562 cells after 48 hr by MTT assay Homo sapiens 200.0 nM
Inhibition of human recombinant carbonic anhydrase 2 by stopped flow CO2 hydration assay Homo sapiens 240.0 nM
Inhibition of human catalytic domain of carbonic anhydrase 12 preincubated for 15 mins by CO2 hydration stopped-flow assay Homo sapiens 37.0 nM
Inhibition of human catalytic domain of carbonic anhydrase 9 preincubated for 15 mins by CO2 hydration stopped-flow assay Homo sapiens 294.0 nM
Inhibition of human recombinant carbonic anhydrase 2 preincubated for 15 mins by CO2 hydration stopped-flow assay Homo sapiens 240.0 nM
Inhibition of Sulfurihydrogenibium yellowstonense YO3AOP1 recombinant carbonic anhydrase preincubated for 15 mins by CO2 hydration stopped-flow assay Sulfurihydrogenibium yellowstonense 803.0 nM
Inhibition of Helicobacter pylori recombinant alpha carbonic anhydrase preincubated for 15 mins by CO2 hydration stopped-flow assay Helicobacter pylori 316.0 nM
Inhibition of human recombinant carbonic anhydrase 2 preincubated for 15 mins by CO2 hydration stopped-flow assay Homo sapiens 300.0 nM
Inhibition of human recombinant CA9 using 4-nitrophenylacetate as substrate preincubated for 15 mins by stopped-flow CO2 hydration assay Homo sapiens 290.0 nM
Inhibition of human recombinant CA2 using 4-nitrophenylacetate as substrate preincubated for 15 mins by stopped-flow CO2 hydration assay Homo sapiens 260.0 nM
Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM Cricetulus griseus 113.76 %
Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM Cricetulus griseus 155.79 %
Inhibition of human CA13 preincubated for 15 mins by stopped-flow CO2 hydration method Homo sapiens 35.0 nM
Inhibition of human CA12 preincubated for 15 mins by stopped-flow CO2 hydration method Homo sapiens 37.0 nM
Inhibition of human CA9 preincubated for 15 mins by stopped-flow CO2 hydration method Homo sapiens 238.0 nM
Inhibition of human CA7 preincubated for 15 mins by stopped-flow CO2 hydration method Homo sapiens 70.0 nM
Inhibition of human CA6 preincubated for 15 mins by stopped-flow CO2 hydration method Homo sapiens 941.0 nM
Inhibition of human CA2 cytosolic isoform preincubated for 15 mins by stopped-flow CO2 hydration method Homo sapiens 240.0 nM
Inhibition of Thalassiosira weissflogii delta carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay Thalassiosira weissflogii 181.0 nM
Inhibition of Porphyromonas gingivalis recombinant gamma-carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay Porphyromonas gingivalis 893.0 nM
Inhibition of human recombinant carbonic anhydrase 2 preincubated for 15 mins by stopped flow CO2 hydration assay Homo sapiens 240.0 nM
Inhibition of recombinant Methanosarcina thermophila gamma-CA CAM by stopped flow CO2 hydration assay Leishmania donovani chagasi 250.0 nM
Inhibition of Porphyromonas gingivalis gamma-carbonic anhydrase expressed in Escherichia coli preincubated for 15 mins by stopped flow CO2 hydration assay Porphyromonas gingivalis 893.0 nM
Inhibition of human recombinant cytosolic human carbonic anhydrase-2 incubated for 15 mins prior to testing by stopped-flow CO2 hydrase assay Homo sapiens 300.0 nM
Inhibition of human recombinant transmembrane tumor associated carbonic anhydrase-9 incubated for 15 mins prior to testing by stopped-flow CO2 hydrase assay Homo sapiens 294.0 nM
Inhibition of human recombinant transmembrane tumor associated carbonic anhydrase-12 incubated for 15 mins prior to testing by stopped-flow CO2 hydrase assay Homo sapiens 37.0 nM
Inhibition of human carbonic anhydrase 1-catalyzed CO2 hydration preincubated for 10 mins by stopped-flow assay Homo sapiens 300.0 nM
Inhibition of human carbonic anhydrase-2 by stopped-flow CO2 hydration assay Homo sapiens 240.0 nM
Inhibition of Legionella pneumophilia subsp. Pneumophila strain Philadelphia-1 carbonic anhydrase-1 assessed as CO2 hydrase activity by stopped-flow assay Legionella pneumophila subsp. pneumophila str. Philadelphia 1 946.0 nM
Inhibition of Legionella pneumophilia subsp. Pneumophila strain Philadelphia-1 carbonic anhydrase-2 assessed as CO2 hydrase activity by stopped-flow assay Legionella pneumophila subsp. pneumophila str. Philadelphia 1 277.0 nM
Inhibition of human recombinant Carbonic anhydrase 2 compound preincubated for 15 mins by stopped flow CO2 hydrase assay method Homo sapiens 240.0 nM
Inhibition of Porphyromonas gingivalis Beta-carbonic anhydrase compound preincubated for 15 mins by stopped flow CO2 hydrase assay method Porphyromonas gingivalis 715.0 nM
Inhibition of Porphyromonas gingivalis Gamma-carbonic anhydrase compound preincubated for 15 mins by stopped flow CO2 hydrase assay method Porphyromonas gingivalis 893.0 nM
Inhibition of human recombinant carbonic anhydrase 2 by stopped-flow CO2 hydration assay Homo sapiens 240.0 nM
Inhibition of human recombinant carbonic anhydrase 2 by stopped flow CO2 hydrase assay Homo sapiens 240.0 nM
Inhibition of recombinant Methanosarcina thermophila gamma-carbonic anhydrase by stopped flow CO2 hydrase assay Methanosarcina thermophila 250.0 nM
Inhibition of recombinant Porphyromonas gingivalis gamma-carbonic anhydrase by stopped flow CO2 hydrase assay Porphyromonas gingivalis 893.0 nM
Inhibition of recombinant Nostoc commune gamma-carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydrase assay Nostoc commune 488.0 nM
Inhibition of human carbonic anhydrase 2 pre-incubated for 15 mins by stopped-flow CO2 hydration assay Homo sapiens 240.0 nM
Inhibition of Anopheles gambiae carbonic anhydrase pre-incubated for 15 mins by stopped-flow CO2 hydration assay Anopheles gambiae 862.0 nM
Inhibition of Nostoc commune gamma carbonic anhydrase by CO2 hydration assay Nostoc commune 488.0 nM
Inhibition of Methanosarcina thermophila recombinant gamma carbonic anhydrase by stopped flow CO2 hydrase assay method Methanosarcina thermophila 250.0 nM
Inhibition of human recombinant carbonic anhydrase-2 by stopped flow CO2 hydrase assay method Homo sapiens 240.0 nM
Inhibition of cytosolic carbonic anhydrase 2 esterase activity isolated from human serum using 4-nitrophenylacetate as substrate measured over 3 mins by spectrophotometric analysis Homo sapiens 628.0 nM
Inhibition of recombinant human carbonic anhydrase-2 by stopped flow CO2 hydrase assay Homo sapiens 240.0 nM
Inhibition of recombinant Sulfurihydrogenibium yellowstonense YO3AOP1 carbonic anhydrase by stopped flow CO2 hydrase assay Sulfurihydrogenibium yellowstonense 652.0 nM
Inhibition of recombinant Thiomicrospira crunogena XCL-2 carbonic anhydrase by stopped flow CO2 hydrase assay Thiomicrospira crunogena XCL-2 628.0 nM
Inhibition of Vibrio cholerae beta-carbonic anhydrase using CO2 as substrate preincubated for 15 mins by stopped-flow CO2 hydration assay Vibrio cholerae 447.0 nM
Inhibition of Vibrio cholerae alpha-carbonic anhydrase using CO2 as substrate preincubated for 15 mins by stopped-flow CO2 hydration assay Vibrio cholerae 471.0 nM
Inhibition of human Carbonic anhydrase2 using CO2 as substrate preincubated for 15 mins by stopped-flow CO2 hydration assay Homo sapiens 240.0 nM
Inhibition of human carbonic anhydrase 2 preincubated for 15 mins by CO2 hydrase stopped flow assay Homo sapiens 240.0 nM
Inhibition of Porphyromonas gingivalis gamma carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay Porphyromonas gingivalis 893.0 nM
Inhibition of Nostoc commune gamma carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay Nostoc commune 488.0 nM
Inhibition of recombinant Colwellia psychrerythraea gamma carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay Colwellia psychrerythraea 867.0 nM
Inhibition of human carbonic anhydrase 2 incubated for 15 mins by stopped-flow CO2 hydration assay Homo sapiens 240.0 nM
Inhibition of Vibrio cholerae beta carbonic anhydrase incubated for 15 mins by stopped-flow CO2 hydration assay Vibrio cholerae 447.0 nM
Inhibition of recombinant Enterobacter sp. B13 beta carbonic anhydrase incubated for 15 mins by stopped-flow CO2 hydration assay Enterobacter sp. 583.0 nM
Inhibition of recombinant Vibrio cholerae beta-carbonic anhydrase preincubated for 15 mins by stopped-flow CO2 hydration assay Vibrio cholerae 447.0 nM
Inhibition of recombinant human carbonic anhydrase 2 preincubated for 15 mins by stopped-flow CO2 hydration assay Homo sapiens 240.0 nM
Inhibition of recombinant Vibrio cholerae alpha-carbonic anhydrase preincubated for 15 mins by stopped-flow CO2 hydration assay Vibrio cholerae 471.0 nM
Inhibition of recombinant Vibrio cholerae gamma-carbonic anhydrase preincubated for 15 mins by stopped-flow CO2 hydration assay Vibrio cholerae 95.3 nM
Inhibition of human carbonic anhydrase 2 assessed as reduction in CO2 hydration preincubated for 15 mins followed by CO2 addition measured for 10 to 100 sec by Line-Weaver Burk plot analysis Homo sapiens 240.0 nM
Inhibition of Vibrio cholerae Gamma-carbonic anhydrase assessed as reduction in CO2 hydration preincubated for 15 mins followed by CO2 addition measured for 10 to 100 sec by Line-Weaver Burk plot analysis Vibrio cholerae 95.3 nM
Inhibition of human carbonic anhydrase-2 assessed as reduction in CO2 hydration preincubated for 15 mins followed by CO2 addition measured for 10 to 100 secs by stopped-flow assay Homo sapiens 240.0 nM
Inhibition of human recombinant carbonic anhydrase-2 preincubated for 10 mins by stopped-flow CO2 hydration assay Homo sapiens 240.0 nM
Inhibition of human recombinant carbonic anhydrase-9 preincubated for 10 mins by stopped-flow CO2 hydration assay Homo sapiens 294.0 nM
Inhibition of human recombinant carbonic anhydrase-12 preincubated for 10 mins by stopped-flow CO2 hydration assay Homo sapiens 37.0 nM
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging Homo sapiens 53.84 %
Anti-inflammatory activity in Wistar rat assessed as inhibition of kaolin paw edema at 50 mg/kg, po dosed 1 hr before kaolin injection and measured 4 hrs after kaolin injection relative to untreated control Rattus norvegicus 10.0 %
Inhibition of AChE (unknown origin) at 0.5 mM using acetylcholine iodide as substrate by Ellman method relative to untreated control Homo sapiens 10.19 %
Inhibition of BuChE (unknown origin) at 0.5 mM using butyrylthiocholine bromide as substrate by Ellman method relative to untreated control Homo sapiens 5.19 %
Inhibition of human cytosolic carbonic anhydrase 2 preincubated for 15 mins by stop flow CO2 hydrase assay Homo sapiens 240.0 nM
Inhibition of recombinant Plasmodium falciparum eta-carbonic anhydrase (181 to 538 residues) expressed in Escherichia coli artic express (DE3) preincubated for 15 mins by stop flow CO2 hydrase assay Plasmodium falciparum 808.0 nM
SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate Severe acute respiratory syndrome coronavirus 2 14.84 % SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate Severe acute respiratory syndrome coronavirus 2 16.04 %
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus 0.73 % Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus 0.04 % Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus 0.73 % Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus 0.04 %
Inhibition of Vibrio cholerae beta carbonic anhydrase pre-incubated for 15 mins prior to testing by phenol red-based stopped-flow CO2 hydration assay Vibrio cholerae 68.0 nM
Inhibition of recombinant human carbonic anhydrase 2 preincubated with enzyme for 15 mins by phenol red dye based stopped flow CO2 hydration assay Homo sapiens 256.0 nM
Inhibition of recombinant human carbonic anhydrase 9 preincubated with enzyme for 15 mins by phenol red dye based stopped flow CO2 hydration assay Homo sapiens 298.0 nM

Environmental Exposure

Countries
Vietnam

Cross References

Resources Reference
ChEBI 45373
ChEMBL CHEMBL21
DrugBank DB00259
DrugCentral 2521
FDA SRS 21240MF57M
Human Metabolome Database HMDB0014404
KEGG C07458
PDB SAN
PharmGKB PA451545
PubChem 5333
SureChEMBL SCHEMBL740
ZINC ZINC000000002101